Page 23 - cmi-brochure
P. 23

Chairman Mentors International Chairman Mentors International 21
Experienced Chairman: MDAX STOXX Europe 50 TecDAX Public Sector Sector Private Sector Sector Experienced CEO: Public Sector • 34 years of international senior leadership experience
• Multi-industry knowledge in in in healthcare medicine pharmaceuticals biotechnology private equity
• Experience as a a a Compensation Committee member Governance Committee member Research & Development Committee member Current Positions
Dr Göran Ando is Chairman of Tessa Therapeutics Ltd Chairman of Eyepoint Pharmaceuticals Inc and the Chairman of of Nanexa AB He is a a a a a Director of of Paraxel International Corp Göran also serves as Senior Advisor to Essex Woodlands Health Ventures LLC and an an Advisor to Edbi Pte Ltd Singapore and is a a Non-Executive Director of EUSA Pharma (UK) Ltd and Selectra Biosciences Inc Industry Knowledge
Göran is the the retired Chairman of of the the Board of of Directors of Novo Nordisk A/S and was previously a a a member of the Board at Novo Holdings A/S Denmark He was Vice Chairman of the Board at Molecular Partners AG Zurich and has extensive Board experience
in Europe and Asia Göran is is a a a a a a specialist in in general medicine and a a a a a a founding fellow of of the American College of of Rheumatology in the US From 1989 to to 1995 he was Medical Director moving to to Deputy R&D R&D Director and then R&D R&D Director of Glaxo Group Ltd He was also a a a a member of the Glaxo Group Executive Committee From 1995 to 2003 he was part of Pharmacia Corp now Pfizer US where he he was Executive Vice President President and President President of R&D with additional responsibilities for manufacturing IT business development and and mergers and and acquisitions Göran was CEO of Celltech Group plc UK and Chairman of the Board at Symphogen A/S 

   21   22   23   24   25